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Summary. Rebamipide, an antiulcer agent, has been 
shown to be able to prevent gastric mucosal injury 
resulting in part from activation of neutrophils. The 
mechanism of its suppressive action, however, remains 
to be established. The present study aimed to determine 
the effect of rebamipide on activation of isolated human 
neutrophils and to identify the signal transduction 
pathway involved in its regulation. In unstimulated cells, 
alkaline phosphatase activity was found residing in short 
rod-shaped intracellular granules. Upon stimulation with 
a chemotactic peptide formyl-methionyl- leucyl-  
phenylalanine, the granules fused to form elongated 
tubular structures and spherical vacuoles. Rebamipide 
inhibited reorganization of alkaline phosphatase- 
containing granules along with upregulation of alkaline 
phosphatase activity and CD16,  a marker of the 
granules. It also suppressed chemotaxis, an increase in 
intracellular calcium ion concentration, and NADPH 
oxidase activation in cells stimulated with formyl- 
methionyl-leucyl-phenylalanine. In contrast, the drug 
showed no inhibitory action toward upregulation of 
alkaline phosphatase activity and CD16, and activation 
of NADPH oxidase in cells stimulated with phorbol 
myristate acetate, an activator of protein kinase C. These 
findings demonstrate that rebamipide exerts a broad 
spectrum of suppressive actions toward biological 
functions of human neutrophils stimulated with formyl- 
methionyl-leucyl-phenylalanine, but not with phorbol 
myristate acetate, and suggest that the upstream point of 
protein kinase C is the signal transduction pathway 
involved in its regulation. 
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Introduction 
Rebamipide (2-(4-chlorobenzoylamino)-3-[2-(1H)- 
quinolinon-4-yllpropionic acid) is known to affect 
various biological functions and was shown as a 
preventer of the damage of gastric mucosa. The chemical 
inhibits nitric oxide production in murine macrophages 
(Nagano et al., 1998) and interleukin-8 release in gastric 
cancer cell lines (Aihara et al., 1998). It also induces 
production of substances essential for reparation of the 
gastric mucosa (for review see Majumdar et al., 1997), 
such as epidermal growth factor, glycosaminoglycan, and 
prostaglandin E2 (Song et al., 1998; Takaishi et al., 1998; 
Tarnawski et al., 1998). In neutrophils, rebamipide 
inhibits production of reactive oxygen species and 
binding of formyl-methionyl-leucyl-phenylalanine 
(FMLP) to cell surface (Ogino et al., 1992; Yoshikawa et 
al., 1993; Naito et al., 1994, 1995; Yoshida et al., 1996; 
Kim and Hong, 1997; Danielsson and Jurstrand, 1998; 
Sakurai et al., 1998; Yamasaki et al., 1999). 
Formation of gastr ic  ulcer is associated with 
activation of neutrophils (Smith et al., 1987; Ogino et 
al., 1992), which tend to accumulate in particular areas 
of the gastric mucosa (Steer, 1985; Watanabe et al., 
1997). Activation of neutrophils is accompanied by the 
release of superoxide. It is produced by the function of 
NADPH oxidase and then subsequently converted to 
reactive oxygen species, including hydrogen peroxide, 
singlet oxygen and hydroxyl radicals which participate 
in microbial killing and cause injury of surrounding 
tissue (for reviews see Robinson and Badway, 1995; 
Babior, 1999; Kobayashi and Seguchi, 1999). 
In human neutrophils, superoxide is produced in a 
special type of intracellular compartments, alkaline 
phosphatase (ALPase)-positive secretory granules 
(Kobayashi et al. ,  1998).  Upon cell  stimulation, 
secretory granules fuse to form elongated tubular 
structures and vacuoles which eventually associate with 
the plasma membrane causing release of superoxide 
outside the cell  (Kobayashi et al. ,  1998,  1999; 
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Kobayashi and Seguchi, 1999). These compartments 
contain membrane proteins involved in inflammatory 
reaction (Borregaard et al., 1993; Borregaard and 
Cowland, 1997). 
In the present study, we evaluated the suppressive 
effect of rebamipide on reorganization of secretory 
granules, upregulation of distinct markers of these 
granules, ALPase activity and CD16, chemoattractant- 
directed migration, an increase in intracellular calcium 
ion concentration, and NADPH oxidase activation in 
isolated human neutrophils. A signal transduction 
pathway involved in regulation of the action of the drug 
is suggested. 
Materials and methods 
Reagents 
Cytochrome c,  dextran (av. MW = 520,000),  
Histopaque 1083, N-formyl-methionyl-leucyl-phenyl- 
alanine (FMLP), p-nitrophenylphosphate, phorbol 12- 
myristate 13-acetate (PMA), poly-l-lysine, superoxide 
dismutase, N-tris[hydroxymethyl]glycine (Tricine) and 
N-tris[hydroxymethyl]methyl-3-aminopropane-sulfoni~ 
acid (TAPS) were purchased from the Sigma Chemical 
Co. (St Louis, MO, USA). Rebamipide was a kind gift 
from Otsuka Pharmaceuticals, Co. Ltd. (Tokushima, 
Japan). Anti-CD16 was obtained from the Novocastra 
Lab. Ltd. (Newcastle, UK). Fluorescein-conjugated 
goat-IgG to mouse IgG was obtained from ICN 
Pharmaceuticals, Inc. (Aurora, OH, USA). Fura 2-AM 
was purchased from Molecular Probes, Inc. (Eugene, 
OR, USA). All other reagents were of the highest grade 
of purity available. Stock solutions of FMLP, PMA and 
Fura 2-AM were prepared in dimethyl  sulfoxide 
(DMSO) and stored at -20 T. 
Isolation of neutrophils 
After  obtaining an informed consent,  human 
neutrophils were isolated from peripheral blood of 
healthy volunteers as previously described (Kobayashi 
and Robinson, 1991). Briefly, leukocytes were separated 
from erythrocytes by sedimentation in 6% dextran with 
acid citrate followed by enrichment centrifugation 
through Histopaque. Residual erythrocytes  were 
removed by hypotonic lysis with distilled water. Cell 
viability was at least 97% as determined by trypan blue 
exclusion and purity of neutrophils was 95% by 
differential counting. Neutrophils were maintained in 
PBS until use. 
Loading with rebamipide and cell stimulation 
Cells (1x106 cellslml) were exposed to 2 mM 
rebamipide in PBS containing 1 mM MgC12, 1 mM 
CaC12 and 5 mM glucose for 10 rnin at 37 !='C followed 
by stimulation with either 1 0 - ~  M FMLP or 50 nglml 
PMA for 5 rnin at 37 V. In some experiments, cells 
were treated with various concentrations of rebamipide 
to examine their dose-dependency. Stock solutions of 
FMLP and PMA were diluted with DMSO so that the 
final concentration of the solvent in cell suspension was 
0.25% (vlv). Unstimulated cells, serving as control, were 
incubated in a similar manner, but without addition of 
either FMLP or PMA. 
Enzyme cytochemistry for ALPase detection 
After loading with rebamipide followed by 
stimulation, cell suspensions were immediately mixed 
with an equal  volume of PBS,  containing 4% 
glutaraldehyde, and fixed for 5 rnin on ice followed by 
centrifugation. The resulting pellet was resuspended in 
PBS, cells were attached onto glass cover slips coated 
with 0.2% poly-l-lysine (Robinson, 1991) and placed in 
cell culture multiwell plates. Fixed cells were rinsed 
with 100 mM TAPS buffer (pH 9.4) and then subjected 
to cytochemical detection of the sites of ALPase activity 
(Kobayashi and Robinson, 1991). Briefly, cells were 
incubated in a reaction medium (pH 9.4) containing 100 
mM TAPS, 5 0  mM Tricine, 2 mM p-nitrophenyl- 
phosphate, 2 mM CeC13, 2 mM MgS04, 0.006% Triton 
X-100, 0.004% saponin and 5% sucrose, for 1 hr at 37 
"C, followed by washing with TAPS buffer. 
Microscopy 
After cytochemical incubation, cells were washed 
with 0.1M cacodylate buffer (pH 7.4). Postfixation was 
performed with 1% osmium tetroxide in cacodylate 
buffer for 30  min on ice followed by a rinse with 
cacodylate buffer. Cells were then dehydrated through a 
graded series of ethanols and embedded in Spurr's epoxy 
resin (Spurr, 1969). Blocks were cut with a Reichert 
OmU4 (Reichert-Jung; Vienna, Austria). Semi-thin (0.5 
p m  in thickness) sections were examined under a 
transmission electron microscope (JEM-100s; JEOL, 
Tokyo, Japan) operated at an accelerating voltage of 80 
kV. For scanning electron microscopy, osmium 
tetroxide-fixed cells were treated with 1% tannic acid 
(Yamasaki et al., 1997), dehydrated in a graded series of 
ethanols, dried in a critical point dryer (Hitachi HCP-2; 
Hitachi, Tokyo, Japan) with liquid CO2 and then coated 
with Pt (5 nm in thickness) in an ion-coater (Eiko IB-5; 
Eiko, Tokyo, Japan). The observation was done with a 
field emission scanning electron microscope (Hitachi S- 
700; Hitachi, Tokyo, Japan) operated at an accelerating 
voltage of 15 kV. 
Measurement of AL Pase activity 
The amount of ALPase activity upregulated to the 
cell surface was determined spectrophotometrically by 
measuring the conversion of p-nitrophenylphosphate to 
p-nitrophenol (Kobayashi and Robinson, 1991). Fixed 
cells ( 1x10~  cells/ml) were incubated for 15 rnin at 37 !='C 
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in a reaction medium as described above with the 
exception that cerium ions and detergents were not used. 
Reaction was stopped by transferring tubes containing 
cell suspension into an ice-cold water bath. Cellular 
materials were removed by rapid centrifugation. 
Resulting supernatant was read at 410 nm. 
Flow cytometry of CD 16 
Cells were fixed with PBS containing 2% 
paraformaldehyde for 30  min on ice followed by 
washing in PBS. Fixed cells were incubated in PBS 
containing 5% normal goat serum and then exposed to 
mouse anti-CD16 IgG for 30 min at 37 "C followed by 
washing in PBS. The cells were further incubated in PBS 
containing fluorescein-conjugated goat IgG to mouse 
IgG for 1 hr at room temperature. Fluorescence intensity 
was analysed in a flow cytometer (FACScan; Becton 
Dickinson, San Jose, CA, USA). 
Chemotaxis assay 
Chemotaxis was assayed using a chemotaxis 
chamber (Chemotaxicell;  Kurabo, Osaka, Japan) 
partitioned by a micropored polycarbonate membrane 
(diameter of pore 5 pm). Upper and lower chambers 
were filled with PBS containing Mg2+, ca2+, glucose 
and rebamipide. Neutrophils (1x10~  cells/ml), exposed 
to rebamipide for 10  min, were added to the upper 
chamber. Then, 10-' M FMLP was added to the lower 
chamber followed by incubation for 10 min at 37 T. 
After incubation, cells were immediately fixed with 2% 
paraformaldehyde in PBS and stained with toluidine 
blue. Micrographs of neutrophils were taken (forty 
micrographs from four separate experiments) and then 
migrating cells were counted in a random-sampling 
manner to determine their number. 
Measurement of intracellular calcium ion concentration 
(tCa2+1i) 
[ca2+l i  was assayed according to Whyte et al. 
(1993). Briefly, cells were incubated for 15 min at 37 "C 
in PBS containing M ~ ~ + ,  Ca2+, glucose and 5 p M  Fura 
2-AM. Fluorescence was determined with a spectro- 
fluorophotometer (Shimadzu RF-5300PC; Shimadzu, 
Kyoto, Japan) employing a dual wavelength excitation 
(340 and 380 nm) and emission at 510 nm. [ca2+li was 
calculated on the basis of R, (obtained by lysing cells 
with 1% Triton X-100) and Rmi, (obtained by adding 40 
mM EGTA to lysed cells). 
Measurement of NADPH oxidase activity 
Superoxide release was measured spectrophoto- 
metrically employing a superoxide dismutase-inhibitable 
reduction of ferricytochrome c (McCord and Fridovich, 
1969). The extent of cytochrome c reduction was 
determined by the change in absorbance at 550 nm with 
a spectrophotometer (Hitachi 220A; Hitachi, Tokyo, 
Japan). The rate of increase in A550 was used to 
calculate the cytochrome c reduction based on a specific 
absorbance of 21.1/mM/cm (Massey, 1959). 
Results 
Mo~phology of neutrophils and localization ofALPase acbLity 
We examined the effect of rebamipide on 
morphology of human neutrophils and localization of 
ALPase activity, a marker of secretory granules. Using 
scanning and transmission electron microscopy, 
unstimulated human neutrophils showed a regular 
spherical outward appearance (Fig. lA ,B) .  Upon 
stimulation with FMLP, the cells revealed marked 
morphological alterations, such as elongated shape and 
presence of pseudopodia (Fig. lC,D). No shape change 
was observed in cells loaded with rebamipide followed 
by stimulation with FMLP (Fig. lE,  F). In unstimulated 
neutrophils, ALPase activity was found in short rod- 
shaped intracellular granules distributed throughout the 
cytoplasm (Fig. 1B). After stimulation with FMLP, 
ALPase activity was seen in elongated tubular structures 
and vacuoles, indicating that secretory granules seen in 
unstimulated cells fuse to form larger structures upon 
stimulation (Fig. ID). Following stimulation with FMLP, 
no reorganization of secretory granules was observed in 
cells exposed to rebamipide (Fig. IF). Upon stimulation 
with PMA, neutrophils were relatively irregular in shape 
and revealed reaction product of ALPase activity in the 
same tubular structures and vacuoles as were observed in 
FMLP-stimulated cells. Morphological alterations were 
not detected in cells stimulated with PMA in the 
presence of rebamipide (data not shown). 
Upregulation of A LPase activity and CD 16 
Association of secretory granules with the plasma 
membrane was studied in stimulated neutrophils by the 
measurement of ALPase activity and cell surface 
expression of CD16 (FcyRIlI), another marker of 
secretory granules. In control, ALPase activity expressed 
to the cell surface was 2.720.8 nm01/30min/lx10~ cells 
(mean2S.D.; n = 4)  in unstimulated neutrophils.  
Rebamipide inhibited upregulation of ALPase activity in 
a dose-dependent manner (Fig. 2). In cells exposed to 
FMLP and to the mixture of rebamipide and FMLP, 
upregulation of ALPase activity was found to be 7.821.3 
and 1.4k0.4 nrn01/30min/lx10~ cells (meankS.D.; n = 
4), respectively (Fig. 3),  indicating that,  upon 
stimulation with FMLP, 2 mM rebamipide inhibits 
82.1% of upregulation of ALPase activity. In cells 
exposed to PMA and to the mixture of rebamipide and 
PMA, upregulated ALPase activity was found to be 
7.520.4 and 7.7k1.0 nm01 /30min / lx10~  cells,  
respectively (Fig. 3), revealing that rebamipide does not 
inhibit  upregulation of ALPase activity in cells 
stimulated with PMA. Then, we measured the cell 

Rebamipide inhibits activation of human neutrophils 
Fig. 1. Scanning electron micrographs showing an outward appearance (A, C, E) of human neutrophils and transmission electron micrographs of thick 
(0.5 pm) sections of the cells demonstrating localization of the sites of ALPase activity (B, D, F). Neutrophils (IxlO%ells/ml) were exposed to 2 mM 
rebamipide in PBS containing 1 mM MgCI2, 1 mM CaCI2 and 5 mM glucose for 10 rnin at 37 "C followed by stimulation with 10-7 M FMLP for 5 min at 
37 "C. A, B. Unstimulated cells are spherical and show ALPase reaction in short rod-shaped secretory granules (arrows). C, D. Cells stimulated with 
FMLP become elongated with pseudopodia (arrows in C) and contain ALPase reaction in tubular structures (double arrow) and vacuoles (arrows) 
formed by fusion of secretory granules. E, F. Cells exposed to the mixture of rebamipide and FMLP are spherical and ALPase reaction is seen in short 
rod-shaped secretory granules (arrows). Bars: 1 pm. 
surface expression of CD16. The relative fluorescence 
intensity based on fluorescence intensity in cells exposed 
to FMLP (regarded as 100%) was 25.928.3, 91.0212.0 
and 88.5216.8 (%tS.D.; n = 3) in cells exposed to the 
mixture of rebamipide and FMLP, to PMA, and to the 
mixture of rebamipide and PMA, respectively (Fig. 4). 
In control, the amount of cell surface expression of 
CD16 was 20.124.9 (%+S.D.; n = 3) in unstimulated 
cells. This result showed that rebamipide inhibited 
upregulation of CD16 (73.5% of inhibition) in cells 
exposed to FMLP, but not to PMA. 
As mentioned above, rebamipide did not induce 
morphological changes of human neutrophils stimulated 
with FMLP. We attempted to elucidate whether it can 
influence the FMLP-induced migration of these cells. 
We employed a chemotaxis chamber partitioned by a 
Concentration of Rebamipide (m M) 
Fig. 2. Suppressive effect of rebamipide on upregulation of ALPase 
activity in human neutrophils stimulated with FMLP. Cells were exposed 
to various concentrations of rebamipide for 10 min at 37 "C followed by 
stimulation with 10-7 M FMLP for 5 rnin at 37 "C. Rebamipide inhibits 
upregulation of ALPase activity in a dose-dependent manner. The data 
represent the mean4.D. from four separate experiments. 
micropored polycarbonate membrane and incubated 
cells for 10 min as described in Materials and Methods. 
The incubation time was critically important for 
counting the polycarbonate membrane-attached 
neutrophils migrating through micropores. Extended 
incubation (over 10 min) resulted in the detachment of 
cells from polycarbonate membrane and their migration 
into the lower chamber, thus decreasing the number of 
membrane-attached cells. Unstimulated cells showed no 
migration pattern under this incubation condition. Figure 
FMLP + + - - 
- 
PMA - + + 
Rebamipide - + - + 
- 
- 
Fig. 3. Effect of rebamipide on upregulation of ALPase activity in human 
neutrophils stimulated with either FMLP or PMA. Cells were exposed to 
2 mM rebamipide for 10 min at 37 "C followed by stimulation with 10-7 M 
FMLP or 50 ng/ml PMA for 5 rnin at 37 "C. Upon stimulation with FMLP, 
2 mM rebamipide inhibits 82.1% of upregulation of ALPase activity. 
Following exposure to PMA and to the mixture of rebamipide and PMA, 
the upregulation of ALPase activity is not affected. The data represent 
the meantS.D. from four separate experiments. 
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FMLP + + 
PMA - - 
Rebamipide - + 
5 is a micrograph of polycarbonate membrane-attached 
migrating cells taken by bringing the surface of the 
membrane facing the lower chamber in focus. Upon 
stimulation with FMLP, more neutrophils migrated to the 
membrane surface facing the lower chamber through the 
membrane pores (Fig. 5A) compared to the number of 
cells stimulated in the presence of rebamipide (Fig. 5B). 
In the latter case, we observed that migrating cells were 
unable to penetrate completely through micropores. 
Rebamipide inhibited FMLP-induced chemotaxis in a 
dose-dependent manner. The number of migrating cells 
counted in a random-sampling manner was determined 
as  1 . 4 1 ? 0 . 3 5 ~ 1 0 ~  and 0 . 0 6 ? 0 . 0 6 ~ 1 0 ~  cells/mm2 
(mean2S.D; n =4) in cells exposed to FMLP and to the 
mixture of rebamipide and FMLP, respectively (Fig. 6), 
meaning that inhibition rate of rebamipide on cell 
migration constituted 95.7%. 
lntracellular calcium ion concentration ([Ca2+Ii) 
Changes in [Ca2+Ii concentration, which is a critical 
Fig. 4. Effect of rebamipide on upregulation of CD16 in human neutrophils stimulated 
with either FMLP or PMA. Cells were exposed to 2 mM rebamipide for 10 min at 37 "C 
followed by stimulation with 10-7 M FMLP or 50 ngtml PMA for 5 min at 37 "C. The 
- - relative fluorescence intensity was calculated on the basis of fluorescence intensity in 
cells exposed to FMLP (regarded as 100%). Rebamipide inhibits 73.5% of CD16 + + upregulation in cells exposed to FMLP, but has little effect toward upregulation of 
- 
CD16 in cells exposed to PMA. The data represent the mean2S.D. from three + separate experiments. 
- 
Fig. 5. Effect of rebamipide on chemotaxis of human neutrophils stimulated with FMLP. Chemotaxis was assayed using a chemotaxis chamber as 
described in Materials and Methods. A. In the absence of rebamipide, a large number of neutrophils (arrows) is seen migrating through micropores in 
membrane (double arrow). B. Rebamipide strongly inhibits the ability of neutrophils to migrate. Arrow shows a neutrophil unable to penetrate 
completely through the micropore in the membrane (double arrow). 
1073 
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signal in the process of mediation between ligand 
recognition and end response, are extremely important 
for various kinds of functional processes in neutrophils 
(for recent review see Pettit et al., 1997). We examined 
the effect of rebamipide on  alteration in [Ca2+Ii 
concentration in neutrophils stimulated with FMLP. 
Stimulation of cells with FMLP caused a rapid increase 
in [Ca2+Ii concentration reaching maximum at 794k120 
nM (mean 5S.D; n = 3). After addition of FMLP, the 
concentration gradually decreased reaching 389251 nM 
by 120 sec (cut off time). Exposure of cells to FMLP in 
the presence of rebamipide induced a slight increase in 
Table l. Effect of rebamipide on NADPH oxidase activation in human 
neutrophils stimulated with either FMLP or PMA. 
TREATMENT* ACTIVITF TOTAL ACTIVITY 
(nmol/min/l XI 06cells) (%l 
FMLP 0.21 k0.05 100 
Rebamipide + FMLP 0.06+0.05 29 
PMA 3.45t0.21 100 
Rebamipide + PMA 3,2920.37 95 
-- 
*: cells were incubated in PBS containing Mg2+, Ca2+ and glucose with 
or without 2 mM Rebamipide for 10 min at 37 "C followed by stimulation 
with either 50 nglml PMA or 10-7 M FMLP at 37 "C. *: activity was 
determined spectrophotometrically by superoxide dismutase-inhibitable 
reduction of ferricytochrome c at 550 nm. Data shown are the mean 
activi1ykS.D. from four separate experiments. 
Concentration of Rebamipide (m M) 
Fig. 6. Suppressive effect of rebamipide on chemotaxis of human 
neutrophils stimulated with FMLP. Chemotaxis was assayed using a 
chemotaxis chamber. Upper and lower chambers were filled with PBS, 
containing Mg2+, Ca2+, glucose and varying concentrations of 
rebamipide, as described in Materials and Methods. Inhibition rate of 
rebamipide on cell migration constitutes 95.7%. The data represent the 
meantS.D. from four separate experiments. 
[ca2+li concentration and a similarly gradual decrease in 
[ca2+li concentration by 120 sec. The value of [ca2+li 
concentration was 236240 nM and 91t17  nM in the 
former and the latter case, respectively. The inhibition 
rate of rebamipide on the increase in [ c a 2 + l i  
concentration was determined as 77.1% (Fig. 7). 
Activation of NADPH oxidase 
The effect of rebamipide on superoxide release in 
cells stimulated with either FMLP or PMA was studied 
by measuring the superoxide dismutase-inhibitable 
reduction of ferricytochrome c. NADPH oxidase activity 
was found to be 0.2120.05 and 0.0620.05 nmol/ 
m i n / l ? 1 0 ~  cells (mean2S.D.; n = 4) in neutrophils 
exposed to FMLP and to the mixture of rebamipide and 
FMLP, respectively (Table 1). Following exposure to 
PMA and to the mixture of rebampide and PMA, activity 
Time (sec) 
Flg. 7. Effect of rebamipide on FMLP-induced intracellular calcium ion 
([CaZ+h) concentration in Fura-2-loaded human neutrophils. Cells were 
incubated for 15 min at 37 "C in PBS containing Mg2+, Ca2+, glucose 
and 5 pM Fura 2-AM followed by exposure to 2 mM rebamipide. 
A. Stimulation with FMLP causes a rapid increase in [Ca2+Ii 
concentration, reaching maximum at 794t120 nM (mean &.D), and a 
slight decrease in [Ca2+Ii concentration reaching 389k51 nM by 120 sec 
(cut off time). B. Exposure of cells to FMLP in the presence of 
rebamipide induces a slight increase in [Ca2+Ii level and a similarly 
gradual decrease in [Ca2+Ii level by 120 sec. An arrow indicates addition 
of 10-7 M FMLP. Each graph is a representative of three separate 
experiments. 
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of the enzyme was detected as 3.4520.21 and 3.2920.37 
n m o l / m i n / l x l ~ ~  cells, respectively (Table 1). These 
results demonstrate that rebamipide inhibited 71% of 
superoxide release in cells stimulated with FMLP. On 
the contrary, rebamipide was unable to affect the 
superoxide production in cells stimulated with PMA. 
Discussion 
The present study demonstrates that rebamipide, an 
antiulcer agent, influences several important biological 
functions of human neutrophils stimulated with FMLP, 
but not with PMA, and suggests that the upstream point 
of protein kinase C is the signal transduction pathway 
involved in its regulation. 
To determine the effect of rebamipide on biology of 
human neutrophils, we evaluated the dynamics of 
ALPase-containing intracellular compartments. This 
type of granules contains several membrane proteins, 
namely membrane factor cytochrome bSs8 of NADPH 
oxidase, adhesion molecule CDllb,  Fc-receptor CD16, 
and FMLP-receptor involved in inflammatory reaction 
(Borregaard et al., 1993; Borregaard and Cowland, 
1997). In early phase of neutrophil activation, ALPase- 
containing granules are mobilized to cell surface during 
stimulation by mediators of inflammation (Borregaard et 
al., 1990; Sengelav et al., 1993). This results in an 
immediate surface expression of cytochrome bSs8 
(Calafat et al. ,  1993).  Our data confirmed that 
rebamipide inhibits an intracellular reorganization of 
secretory granules, which fuse to form elongated tubular 
structures and vacuoles, concomitantly with the surface 
expression of markers of secretory granules, ALPase 
activity and CD16. This indicates that rebamipide acts to 
immobilize essential inflammatory membrane proteins 
and to prevent them from moving toward the cell 
surface. We found no morphological changes in cells 
exposed to the mixture of rebamipide and FMLP, 
although in the absence of rebamipide FMLP-stimulated 
cells became elongated in shape and showed 
pseudopodia. 
We tested whether rebamipide is able to affect the 
chemotaxis in human neutrophils, since rearrangement 
of actin filaments is known to induce chemotaxis along 
with formation of pseudopodia upon cell stimulation 
(Moffat et al., 1996; Luna et al., 1997; Bernard et al., 
1999;  Middelhoven et al. ,  1999). We found that 
rebamipide inhibits FMLP-induced neutrophil migration, 
therefore suggest ing that the drug influences 
rearrangement of cytoskeleton. Experiments are 
presently under way to elucidate whether rebamipide 
affects the rearrangement of actin filaments in human 
neutrophils stimulated with FMLP. 
Since activation of N-formyl peptide receptor in 
human neutrophils by ligands, such as FMLP, induces an 
increase in [ c a 2 + l i  concentration together with 
chemotaxis (Miettinen et al., 1998), we examined the 
effect of rebamipide on an increase in [ c a 2 + l i  
concentration. It was found that rebamipide inhibits an 
increase in [ca2+li concentration by 77.1%, and that 
[ca2+li concentration is gradually reduced to levels 
detected in unstimulated cells by 120  sec after 
stimulation with FMLP. These observations are in 
agreement with data obtained in experiments by 
Murakami et al. (1998). 
Previously, we postulated that cytosolic factors of 
NADPH oxidase are associated with membrane factors 
localized in secretory granules and demonstrated that 
superoxide is released extracellularly by fusion of the 
granules to the plasma membrane (Kobayashi and 
Seguchi, 1999). These results are supported by the recent 
report of Telek et al. (1999). The authors used confocal 
laser scanning microscopy to elegantly demonstrate that 
the reactive oxygen species originate from intracellular 
compartments to be released extracellularly upon 
stimulation. To further confirm the previous 
observations, we show herein the suppressive effect of 
rebamipide on extracellular release of superoxide in cells 
stimulated with FMLP by measuring the reduction of 
cytochrome c (McCord and Fridovich, 1969). 
Employing methods based on different principles of 
detection, rebamipide was shown as an inhibitor of 
superoxide production in FMLP-stimulated cells in 
studies utilizing such assays like luminol-enhanced 
chemiluminescence and flow cytometry (Danielssonn 
and Jurstrand, 1998). The former measures amount of 
reactive oxygen species inside and released outside the 
cells (Fredlund et al., 1988), while the latter detects the 
amount of reactive oxygen species solely inside the cells 
(Perticarari et al., 1994). Findings of the present study, in 
agreement with the report mentioned above 
(Danielssonn and Jurstrand, 1998), demonstrate that 
rebamipide inhibits activation of NADPH oxidase in 
secretory granules and that superoxide is laborious to be 
released extracellularly even when the enzyme is 
partially activated in cells stimulated with FMLP in the 
presence of rebamipide, since rebamipide suppresses 
association of secretory granules with the plasma 
membrane. 
To clarify the mechanism of rebamipide action, we 
examined the effect of the drug on neutrophil functions 
upon stimulation with PMA as compared to FMLP. We 
found that alterations in neutrophils morphology, 
mobilization of ALPase-containing secretory granules, 
upregulation of ALPase activity and CD16, and 
activation of NADPH oxidase are all suppressed by 
rebamipide in cells exposed to FMLP, but not to PMA. 
The latter is  known to activate protein kinase C 
(Nishizuka, 1986) which is physiologically stimulated 
by diacylglycerol. The cell surface receptors including 
FMLP receptor are linked to heterotrimeric guanosine 
5'-triphosphate-binding proteins which participate in the 
activation of phosphoinositide-specific phospholipase C. 
This phospholipase, in turn, generates diacylglycerol and 
inositol 1,4,5-triphosphate as second messengers of 
signal transduction (Boulay et al., 1990; Bokoch, 1995). 
Binding of inositol 1,4,5-triphosphate to ca2+ stores 
induces the release of ca2+ to the cytosol (Clapham, 
Rebamipide inhibits activation of human neutrophils 
1995). It is likely, therefore, that the upstream point of 
protein kinase C is involved in the suppressive action of 
rebamipide shown in this study. It was reported that 
rebamipide inhibits production of reactive oxygen 
species through the blocking of FMLP-related receptors 
(Danielsson and Jurstrand, 1998) and that i t  shows 
decrease in binding of FMLP to neutrophils (Kim and 
Hong, 1997). At least two mechanisms may therefore be 
considered with respect to the suppressive effect of 
rebamipide on neutrophil function: (1) the drug affects 
neutrophils through direct binding to FMLP receptor, 
and (2) it acts through inhibition of exocytosis of 
secretory granules by suppressive action to the point 
other than FMLP receptor, because secretory granules 
are the storage of FMLP receptors and deliver them to 
the cell surface upon stimulation. 
In conc lus~on ,  results of the present study 
demonstrate that rebamipide inhibits exocytosis of 
secretory granules, chemotaxis, an increase in ca2+li 
concentration and release of su eroxide in L uman 
neutrophils stimulated with FMLP, put not with PMA. It 
is suggested that the upstream point of protein kinase C 
is the signal transduction pathway involved in its 
regulation. 
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